CSPAN2 Today In Washington June 23, 2011
8600 newborns with high genetic risks for the disease, and we plan to follow them for 15 years. we will be collecting biological samples and information about their lives, identification comfortable, of an infectious agent that triggers this auto immunity could lead to a vaccine to protect against this disorder. .. is conducting trials of promising therapies in newly diagnosed patients. now, the third handoff continues along a spectrum of disease progression and this next age of disease research shown in green focus is on people with established type one diabetes. and a high priority...